BriaCell Therapeutics Corp. retweeted
Late-Stage Immunotherapy. Nearing Key Readout.
@BriaCell is advancing a Phase 3 immunotherapy for metastatic breast cancer—targeting patients with limited treatment options.
Here’s what stands out:
• Phase 3 trial nearing key readout for lead therapy
• Precision approach using patient-specific markers
• Designed to work with checkpoint inhibitors
• Broader pipeline targeting multiple cancers
The focus now:
move through late-stage Phase 3 trial toward potential approval.
Advanced science.
Late-stage progress.
A new approach to cancer care.
Learn more: hubs.li/Q04fLhJB0
BriaCell Therapeutics Corp. retweeted
Dr. @CarmenCalfa joined @OncologyCentral to discuss her poster presentation at #ASCO25, which highlighted survival results for Bria-IMT + checkpoint inhibitors for metastatic breast cancer (MBC) patients. Read key takeaways from her #research, the impact of HLA matching on clinical outcomes and valuable advice: loom.ly/eCfhwhA. 🔬
BriaCell Therapeutics Corp. retweeted
Bria-IMT (SV-BR-1-GM; @BriaCell) treatment, in combination with retifanlimab, yielded a 71% intracranial objective response rate in patients with advanced #BreastCancer and central nervous system metastases.
cgtlive.com/view/bria-imt-ce…
BriaCell Therapeutics Corp. retweeted
Dr. William Williams SABCS 2022 - SV-BR-1-GM: Pooled Analysis Predicts PFS and OS - How Will the Decreases in Circulating Tumor Associated Cells Help Pts with Metastatic Breast Cancer? @BriaCell #SABCS22 #BreastCancer
Read and Share the Article Here:
medicusnetworks.net/3BFRT4q
ALT Dr. William Williams SABCS 2022 - SV-BR-1-GM: Pooled Analysis Predicts PFS and OS - How Will the Decreases in Circulating Tumor Associated Cells Help Pts with Metastatic Breast Cancer?
BriaCell Therapeutics Corp. retweeted
SV-BR-1-GM: Whole Cell Therapeutic Vaccine in Advanced Metastatic Breast Cancer Dr. William Williams SABCS 2022 - What is the Bria-IMT? @BriaCell #SABCS22 #BreastCancer
Watch and Share the Video Here:
medicusnetworks.net/3WcnuCy
ALT SV-BR-1-GM: Whole Cell Therapeutic Vaccine in Advanced Metastatic Breast Cancer Dr. William Williams SABCS 2022 - What is the Bria-IMT and How Will This Help Patients?
BriaCell Therapeutics Corp. retweeted
Come and check out our poster @SABCSSanAntonio @SylvesterCancer trial is open for stage 4 pts with breast cancer and results are promising . #bcsm #MBC #MedTwitter – at San Antonio, TX
BriaCell Therapeutics Corp. retweeted
🚀 We are thrilled to share our research collaboration and license agreement with @BriaCell.
Read more on the press release here: ipatherapeutics.com/ipas-sub…
#IPAtherapeutics #drugdiscovery #antibodydiscovery #biotech
BioStrand, the AI-driven in silico discovery subsidiary of IPA, has entered into a research collaboration and license agreement with BriaCell Therapeutics, a clinical-stage biotechnology company...
bit.ly/3Bq8b1l
$IPA $BCTX @BriaCell
BriaCell Therapeutics Corp. retweeted
See the extended version of our discussion with @BriaCell's CEO Dr. Williams and our review of the recent @sitcancer poster here:
Extended: youtu.be/gOLer1euaGA
SITC: youtu.be/mR-tPSSMsGc
We received compensation for producing this video. See BriaCell's latest presentation and further necessary disclosures here: assets.website-files.com/606…
#oncology #Immunotherapy #breastcancer #breastcancerawareness #Biotechnology
BriaCell Therapeutics Corp. retweeted
Congrats to our resident company @BriaCell for all their amazing achievements in 2021! Check out this video to learn more. #biotech #startups
BriaCell Therapeutics Corp. had a stellar 2021. Check out the highlights from their previous year in the latest video by Small Cap Voice! $BCTX buff.ly/3g8xLNe #breastcancer #clinicaltrials #cancertherapies #advancedbreastcancer
BriaCell Therapeutics Corp. retweeted
Using only standard tissue biopsy slides and artificial intelligence (AI), scientists from Case Western Reserve have identified new biomarkers for breast cancer that can predict whether the cancer will return after treatment. Learn more: ow.ly/fGdI50FTGKO
BriaCell Therapeutics Corp. retweeted
CEO Interview - Dr. Bill Williams, CEO BriaCell: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments bit.ly/inn_ceobwill @BriaCell #biotech #breastcancer #clinicaltrials #investing
BriaCell Therapeutics Corp. retweeted
BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders @briacell bit.ly/2HmCB7v
BriaCell Therapeutics Corp. retweeted
New research published in the journal Oncogene uncovers a protein that helps breast cancer to spread. The findings may lead to new therapies for invasive breast cancer. twgbreastcancer.com/2018/06/…
BriaCell Therapeutics Corp. retweeted
Dynamic discussion by @ErikaHamilton9 @SarahCannonDocs of @drjennifergao @FDAOncology data showing CDK4/6i benefit all subgroup of mBC #bcsm #ASCO18
BriaCell Therapeutics Corp. retweeted
#ASCO18: CDK4/6 inhibitors continue to transform the management of HR+ metastatic #BreastCancer. What about sequencing and options post-CDKi progression? #BCSM #DRGOncology
BriaCell Therapeutics Corp. retweeted
So much traffic at the FB-10 poster I had to wait in line to see the PK data! Excellent and important work from @jamecancerdoc and collaborators
BriaCell Therapeutics Corp. retweeted
Adi Diab: showing how SD became PRs over time in 1L RCC w/ NKTR-214 + nivo #asco18
BriaCell Therapeutics Corp. retweeted
Exciting to see data on #DS8201 #ZW25 #tucatinib #SYD985 and how they will further transform metastatic #HER2 targeted therapy.. The HER2 low reopens another chapter! Clinical trials important! #ASC018 #bcsm xitter.cf/hoperugo/status/100298…
Sara Tolaney summary of HER2 posters in the discussion setting #ASCO2018 DS8201 presented by Iwata et al Friday exciting data in HER2 low as well but pneumonitis is a risk
